American Pharmaceutical Ingredients

71 recalls Categories: Other Drugs, Prescription Drugs

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Feb 9, 2018 Prescription Drugs Nationwide View Details →

Labeling: Not Elsewhere Classified. Manufacturer and product were discovered to be on FDA Import Alert 66-66 for misbranding of active pharmaceutical ingredient.

Jun 1, 2017 Prescription Drugs Nationwide View Details →